In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
- 16 May 2011
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 409 (1-2), 278-288
- https://doi.org/10.1016/j.ijpharm.2011.02.037
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor modelsInvestigational New Drugs, 2010
- Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticlesJournal of Controlled Release, 2010
- Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxelInternational Journal of Pharmaceutics, 2009
- Sequence-Level Population Simulations Over Large Genomic RegionsGenetics, 2007
- Genetic Association Mapping via Evolution-Based Clustering of HaplotypesPLoS Genetics, 2007
- Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort studyThe Lancet Neurology, 2006
- Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistancePharmacogenetics and Genomics, 2006
- Semi-Supervised Methods to Predict Patient Survival from Gene Expression DataPLoS Biology, 2004
- Wetting and absorbency of nonionic surfactant solutions on cotton fabricsColloids and Surfaces A: Physicochemical and Engineering Aspects, 2001
- Efficient algorithms for inferring evolutionary treesNetworks, 1991